Suchergebnisse - "Su, Chi-Ting"

PubPharm (52)

1

LTBP4 Protects Against Renal Fibrosis via Mitochondrial and Vascular Impacts

enthalten in: Circulation research | 2023

von Su, C. | See, D. | Huang, Y. | +8

2

Formulation Development of Doxycycline-Loaded Lipid Nanocarriers using Microfluidics by QbD Approach

enthalten in: Journal of pharmaceutical sciences | 2023

von Lee, C. | Su, C. | Tsai, T. | +4

3

Perirenal IgG4-related disease

enthalten in: Kidney international | 2023

von Wang, W. | Su, C. | Lin, W. | +2

4

Delivery of sorafenib by myofibroblast-targeted nanoparticles for the treatment of renal fibrosis

enthalten in: Journal of controlled release : official journal of the Controlled Release Society | 2022

von Cheng, H. | Huang, H. | Lee, T. | +17

5

Lipid-Based Nanocarriers in Renal RNA Therapy

enthalten in: Biomedicines | 2022

von Su, C. | See, D. | Huang, J.

6

LTBP4 affects renal fibrosis by influencing angiogenesis and altering mitochondrial structure

enthalten in: Cell death & disease | 2021

von Su, C. | Jao, T. | Urban, Z. | +5

7

LTBP4 in Health and Disease

enthalten in: Genes | 2021

von Su, C. | Urban, Z.

8

The biochemical and electrophysiological profiles of amniotic fluid-derived stem cells following Wnt signaling modulation cardiac differentiation

enthalten in: Cell death discovery | 2019

von Liu, Y. | Fang, Y. | Su, C. | +3

9

Severe aortic arch calcification predicts mortality in patients undergoing peritoneal dialysis

enthalten in: Journal of the Formosan Medical Association = Taiwan yi zhi | 2017

von Wu, C. | Lee, Y. | Lee, W. | +5

CommentIn: J Formos Med Assoc. 2018 Jan;117(1):85-86. - PMID 28988889

10

Arrhythmogenesis : a Roadblock to Cardiac Stem Cell Therapy

enthalten in: Current treatment options in cardiovascular medicine | 2016

von Liu, Y. | Su, C. | Yen, C. | +2

1
2
3
4
5
6
Nächster »
[6]